NEUROGENE

neurogene-logo

Neurogene is a developer of generic medicines intended to improve patient outcomes for neurological disorders.The company's offerings include advancing genetic medicines for many neurological disorders where no effective treatment options exist, providing patients and families affected by rare neurological disorders with gene therapy that improves quality of life.

#SimilarOrganizations #People #Financial #Website #More

NEUROGENE

Social Links:

Industry:
Biotechnology

Founded:
2018-01-01

Address:
New York, New York, United States

Country:
United States

Website Url:
http://www.neurogene.com

Total Employee:
11+

Status:
Active

Total Funding:
68.5 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics Apple Mobile Web Clips Icon Google Tag Manager WordPress Content Delivery Network


Similar Organizations

autobahn-therapeutics-logo

Autobahn Therapeutics

Autobahn Therapeutics is a developer of regenerative medicines to restore hope for people affected by CNS disorders.

rainier-therapeutics-logo

Rainier Therapeutics

Rainier Therapeutics is a developer of cancer therapeutics technology intended to offer advanced targeted therapy for bladder cancer.

tiburio-therapeutics-logo

Tiburio Therapeutics

Tiburio Therapeutics is a developer of drug compounds intended to treat tumors and endocrine diseases.


Current Advisors List

srdjan-stankovic_image

Srdjan Stankovic Member Board Of Directors @ Neurogene
Board_member
2019-02-01

Current Employees Featured

rachel-mcminn_image

Rachel McMinn
Rachel McMinn President & CEO @ Neurogene
President & CEO
2018-01-01

steve-pincus_image

Steve Pincus
Steve Pincus Executive Director Analytical Development @ Neurogene
Executive Director Analytical Development
2021-02-01

Founder


rachel-mcminn_image

Rachel McMinn

Investors List

ecor1-capital_image

EcoR1 Capital

EcoR1 Capital investment in Series A - Neurogene

samsara-biocapital_image

Samsara BioCapital

Samsara BioCapital investment in Series A - Neurogene

redmile-group_image

Redmile Group

Redmile Group investment in Series A - Neurogene

cormorant-asset-management_image

Cormorant Asset Management

Cormorant Asset Management investment in Series A - Neurogene

Official Site Inspections

http://www.neurogene.com Semrush global rank: 3.58 M Semrush visits lastest month: 4.02 K

  • Host name: 141.193.213.10
  • IP address: 141.193.213.10
  • Location: United States
  • Latitude: 37.751
  • Longitude: -97.822
  • Timezone: America/Chicago

Loading ...

More informations about "Neurogene" on Search Engine